glp-1 list of drugs approved and pending medications The popularity of GLP-1 drugs
Description
Clinical evidence (based on the literature) on GLP-1 RAs licensed in South Asia or under regulatory approval in one or more South Asian countries is presented and based on prescription pattern and the geography of the reported patient group
Reich, N
Trapp S, Brierley DI
Girish PJ, Abdelmalak BB, Weigal WA, et al
Reply The Medicare.gov Bridge Program website, under Eligibility, indicates 30 bmi+ with prediabetes is eligible
New England Journal of Medicine, 375 ,
